Tissue biomarkers (BIOM) in colon cancer (COC): The translational study on the randomized phase III trial comparing infused irinotecan / 5-fluorouracil.
CTO - Clinical Trials/Research in the Ontology of Biomedical Investigation Richard H. Scheuermann U.T. Southwestern Medical Center.
A Report from ASCO 2007 Adjuvant Colorectal Cancer
Richard H. Scheuermann U.T. Southwestern Medical Center
CTO - Clinical Trials/Research in the Ontology of Biomedical Investigation
